Valuation : Abbott Laboratories

Market Cap 176B 900B 152B 144B 130B 245B 16,854B 246B 1,709B 657B 8,574B 663B 648B 27,094B P/E 2026 *
28.9x
P/E 2027 * 22.4x
Enterprise Value 200B 1,022B 173B 163B 148B 278B 19,141B 279B 1,941B 747B 9,738B 752B 736B 30,771B EV / Sales 2026 *
3.99x
EV / Sales 2027 * 3.62x
Free-Float
86.16%
Yield 2026 *
2.52%
Yield 2027 * 2.69%
1 day-12.14%
1 week-5.70%
Current month-8.21%
1 month-8.46%
3 months+18.74%
6 months-7.78%
Current year-23.80%
1 week 43.27
Extreme 43.27
46.35
1 month 43.27
Extreme 43.27
50.35
Current year 33.5
Extreme 33.5
57.5
1 year 33.5
Extreme 33.5
61.82
3 years 33.5
Extreme 33.5
67.65
5 years 33.5
Extreme 33.5
67.65
10 years 10.4
Extreme 10.403333
67.65
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Change 5-day change 1-year change 3-year change Capi.($)
-12.14%-5.70% - - 176B
-1.36%-5.89%-23.76%-0.44% 176B
-0.72%-3.41%-3.26%+12.32% 116B
+0.19%-2.83%+6.30%+80.17% 61.36B
-1.92%-6.01%+7.05%+38.44% 49.42B
+0.81%-3.73%-4.81%-32.56% 48.44B
-1.75%-5.54%+8.93%-20.82% 31.33B
+0.43%-11.10% - - 28.54B
+0.58%+1.84%+36.58%-12.08% 24.37B
+0.49%-7.65%-13.30%+3.79% 21.57B
Average -1.54%-5.08%+1.72%+8.60% 61.98B
Weighted average by Cap. -3.44%-4.90%-6.02%+10.83%

Financials

2026 *2027 *
Net sales 50.2B 256B 43.26B 40.96B 37.12B 69.65B 4,796B 70B 486B 187B 2,440B 189B 184B 7,711B 54.53B 278B 46.98B 44.48B 40.32B 75.64B 5,209B 76.03B 528B 203B 2,650B 205B 200B 8,375B
Net income 6.3B 32.16B 5.43B 5.14B 4.66B 8.74B 602B 8.79B 61.07B 23.49B 306B 23.67B 23.15B 968B 7.98B 40.71B 6.87B 6.51B 5.9B 11.07B 762B 11.12B 77.3B 29.72B 388B 29.96B 29.3B 1,225B
Net Debt 23.94B 122B 20.63B 19.53B 17.7B 33.21B 2,287B 33.38B 232B 89.2B 1,164B 89.91B 87.93B 3,677B 20.96B 107B 18.06B 17.1B 15.5B 29.07B 2,002B 29.22B 203B 78.09B 1,019B 78.71B 76.98B 3,219B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
26-09-11 R$43.71 -0.75% 318
26-09-10 R$44.04 -2.20% 70
26-09-09 R$45.03 -0.16% 7
26-09-08 R$45.10 -2.70% 320
26-09-04 R$46.35 +0.02% 11
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
101.95USD
Average target price
120.26USD
Spread / Average Target
+17.96%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!